Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Developing better treatments and an improved understanding of the biology behind brain injury from hemorrhagic strokes is the main goal of a three-year $2.8 million grant to the Translational Genomics Research Institute, Phoenix Children's Hospital, and Barrow Neurological Institute.

9 Sep 2015

Exclusive breastfeeding should be supported in women with MS

Exclusive breastfeeding appears to have a protective effect against the return of disease activity after pregnancy in women with multiple sclerosis, say researchers.

9 Sep 2015

Researchers reveal molecular mechanism that controls remyelination

Researchers in Japan have revealed the molecular mechanism involved in the process of repair to damage of the myelin sheath. In vertebrates, axons extending from nerve cells are covered by insulating sheets called the myelin sheath, made with the cell membranes of oligodendrocytes, enabling fast electrical signaling through saltatory conduction.

4 Sep 2015

Diabetes may be linked to buildup of brain tangles associated with Alzheimer’s disease

Diabetes may be linked to the buildup of tangles or tau in the brain, separate from Alzheimer's disease, according to a new study published in the September 2, 2015, online version of Neurology, the medical journal of the American Academy of Neurology.

3 Sep 2015

Perrigo: Shareholders may reject Mylan' offer

Perrigo Company plc today commented on the Mylan N.V. shareholder vote regarding its planned unsolicited offer to acquire Perrigo.

29 Aug 2015

Perrigo closes acquisition of leading OTC brands from GSK

Perrigo Company plc today announced that it has completed the acquisition of leading OTC brands from GSK in an all cash transaction valued at €200 million. The transaction is a clear demonstration of Perrigo's unique ability to maximize brand value across the Company's leading European distribution network spanning 36 countries.

28 Aug 2015

Cryoport to support future clinical trials for Opexa's personalized T-cell immunotherapy programs for MS, NMO

Cryoport, Inc., the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that its validated cryogenic logistics solution will support future clinical trials for Opexa Therapeutics' lead personalized T-cell immunotherapy programs for Multiple Sclerosis ("MS") and Neuromyelitis Optica ("NMO").

27 Aug 2015

Dementia sufferers may begin to lose awareness of memory problems 2-3 years before onset

People who will develop dementia may begin to lose awareness of their memory problems two to three years before the actual onset of the disease, according to a new study published in the August 26, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

27 Aug 2015

Mental visual imagery training may improve AM/EFT functioning in RR-MS patients

Patients with relapsing-remitting multiple sclerosis (RR-MS), the most common form of the disease, often have deficits in two neuropsychological functions, autobiographical memory (AM) and episodic future thinking (EFT), which impact quality of life.

26 Aug 2015

Cognitive factors associated with activity, participation in everyday life among people with MS

Kessler Foundation researchers found that processing speed is the primary limiting factor associated with activity and participation in everyday life among people with multiple sclerosis (MS). "Factors that moderate activity limitation and participation restriction in people with multiple sclerosis" was published in the American Journal of Occupational Therapy.

24 Aug 2015

Stress hormone cortisol tied to thinking problems in healthy older people

Testing the saliva of healthy older people for the level of the stress hormone cortisol may help identify individuals who should be screened for problems with thinking skills, according to a study published in the August 19, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

20 Aug 2015

Early exposure to inflammatory cytokines can paralyze CD4 T cells

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can "paralyze" CD4 T cells, immune components that help orchestrate the body's response to pathogens and other invaders.

19 Aug 2015

Survey identifies key factors linked to pediatric safety events in out-of-hospital emergent care situations

A national survey of more than 750 emergency medical services providers conducted by researchers at Oregon Health & Science University identified airway management skills, personal anxiety and limited pediatric care proficiency among key factors that may contribute to pediatric safety events for children in out-of-hospital emergent care situations.

19 Aug 2015

Physical activity linked to reduced paediatric MS burden

A cross-sectional study has found an association between moderate or strenuous physical activity and reduced fatigue, lesion volumes and relapse rates in children and adolescents with multiple sclerosis.

18 Aug 2015

Nuclear process in the brain may play critical role in health and disease

Every brain cell has a nucleus, or a central command station. Scientists have shown that the passage of molecules through the nucleus of a star-shaped brain cell, called an astrocyte, may play a critical role in health and disease.

18 Aug 2015

Kessler Foundation researcher confirms link between sleep disturbances and MS-related fatigue

Kessler Foundation's Lauren Strober, PhD, explores the association of secondary fatigue and sleep disturbances in multiple sclerosis (MS). "Fatigue in multiple sclerosis: a look at the role of poor sleep" was published in Frontiers in Neurology.

18 Aug 2015

Inhibikase Therapeutics launches observational clinical study in patients who survived PML

Inhibikase Therapeutics, Inc. announces the launch of an observational clinical study in patients who contracted Progressive Multifocal Leukoencephalopathy (PML), the rare and often fatal brain infection that arises as an unintended side effect of some medications used for treatment of Multiple Sclerosis, Crohn's disease, Ulcerative Colitis and certain cancers of the blood and lymph.

13 Aug 2015

Netrin1 protein acts as cellular "marriage broker"

Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made a breakthrough in understanding an important protein that appears to act as a kind of cellular "marriage broker."

13 Aug 2015

Regular exercise benefits children with multiple sclerosis

A new study suggests children with multiple sclerosis (MS) who exercise regularly may have a less active disease. The research is published in the August 12, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

13 Aug 2015

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Intrexon Corporation, a leader in synthetic biology, and Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, today announced an Exclusive Channel Collaboration (ECC) to pursue the development and commercialization of novel biotherapeutics for the treatment of patients with phenylketonuria (PKU), a serious and debilitating metabolic disorder.

10 Aug 2015

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

New $2.8 million NIH grant to help researchers find better treatments for hemorrhagic strokes

Exclusive breastfeeding should be supported in women with MS

Researchers reveal molecular mechanism that controls remyelination

Diabetes may be linked to buildup of brain tangles associated with Alzheimer’s disease

Perrigo: Shareholders may reject Mylan' offer

Perrigo closes acquisition of leading OTC brands from GSK

Cryoport to support future clinical trials for Opexa's personalized T-cell immunotherapy programs for MS, NMO

Dementia sufferers may begin to lose awareness of memory problems 2-3 years before onset

Mental visual imagery training may improve AM/EFT functioning in RR-MS patients

Cognitive factors associated with activity, participation in everyday life among people with MS

Stress hormone cortisol tied to thinking problems in healthy older people

Early exposure to inflammatory cytokines can paralyze CD4 T cells

Survey identifies key factors linked to pediatric safety events in out-of-hospital emergent care situations

Physical activity linked to reduced paediatric MS burden

Nuclear process in the brain may play critical role in health and disease

Kessler Foundation researcher confirms link between sleep disturbances and MS-related fatigue

Inhibikase Therapeutics launches observational clinical study in patients who survived PML

Netrin1 protein acts as cellular "marriage broker"

Regular exercise benefits children with multiple sclerosis

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in